Home › NDC Lookup › Labelers › Revance Therapeutics, Inc.

Revance Therapeutics, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 72960 (Revance Therapeutics, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

2
Package NDCs
1
Products
1
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
botulinum toxin type A 1
By dosage form
INJECTION, POWDER, LYOPHILIZED, FO... 1

Browse records — 1 product

Drug / product Billing NDC NADAC / unit Status
DAXXIFY botulinum toxin type A 100 U/1.2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Revance · NDC 72960-0112-01 · J0589 · 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE 72960-0112-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.